摘要
简介:使用CRISPR / Cas9技术进行靶向基因组编辑,由于其在治疗遗传疾病方面具有很高的潜力,正在成为一个主要的研究领域。我们对这种方法的理解近年来有所扩大,但是我们在探索这一令人兴奋的新技术的界限时也遇到了一些新的挑战。其中最主要的是提高效率,同时也提高了基因组编辑的准确性。 CRISPR / Cas9技术的功效部分依赖于使用主要DNA修复途径之一,同源重组(HR),其主要在细胞周期的S期和G2期有活性。问题在于,从细胞类型到细胞类型,HR潜力是高度可变的,并且大部分在体内靶向用于精确基因组编辑的目标细胞处于静止状态。 结论:在这篇综述中,我们讨论了最近在改进基于CRISPR / Cas9的基因组编辑方面的进展,以及将这种技术体内运送到感兴趣的细胞的有前途的方法。
关键词: CRISPR-Cas9,基因编辑,非同源末端连接,同源重组,DNA修复。
Current Gene Therapy
Title:CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo
Volume: 17 Issue: 4
关键词: CRISPR-Cas9,基因编辑,非同源末端连接,同源重组,DNA修复。
摘要: Introduction: Targeted genome editing using the CRISPR/Cas9 technology is becoming a major area of research due to its high potential for the treatment of genetic diseases. Our understanding of this approach has expanded in recent years yet several new challenges have presented themselves as we explore the boundaries of this exciting new technology. Chief among these is improving the efficiency but also the preciseness of genome editing. The efficacy of CRISPR/Cas9 technology relies in part on the use of one of the major DNA repair pathways, Homologous recombination (HR), which is primarily active in S and G2 phases of the cell cycle. Problematically, the HR potential is highly variable from cell type to cell type and most of the cells of interest to be targeted in vivo for precise genome editing are in a quiescent state.
Conclusion: In this review, we discuss the recent advancements in improving targeted CRISPR/Cas9 based genome editing and the promising ways of delivering this technology in vivo to the cells of interest.
Export Options
About this article
Cite this article as:
CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo, Current Gene Therapy 2017; 17 (4) . https://dx.doi.org/10.2174/1566523217666171122094629
DOI https://dx.doi.org/10.2174/1566523217666171122094629 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements